Innovative Health LLC v. Biosense Webster, Inc.

J&J Unit's Catheter Tying Policy Hurt Rival, Antitrust Jury Told

Innovative Health's CEO told a California federal jury considering its antitrust claims Wednesday that Johnson & Johnson unit Biosense Webster enforced a policy to cut off support to hospitals that didn't use its catheters after Innovative received FDA approval to reprocess Biosense's electrophysiology catheters, devastating Innovative's business.